WuXi AppTec launched the mobile version of OncoWuXi in Oct 2015, the first App in the world, to allow researchers to access oncology models and data. The OncoWuXi App helps researchers anywhere and at any time to identify relevant tumor models for use in anti-tumor efficacy testing to facilitate oncology drug discovery and translational oncology, as well as to keep up-to-date on WuXi’s capabilities and services in this area.

Oncology models, tumor models, anti-tumor efficacy testing, PDX, syngeneic, PBMC, CDX xenograft mouse models

The OncoWuXi App provides users with a portable oncology database for selection and inquiry of the more than 1,000 cancer patient-derived xenograft (PDX), human cancer cell-derived xenograft (CDX), and syngeneic mouse tumor models available at WuXi AppTec. Its backend database covers every aspect of those models, including growth dynamics, histopathology, clinical information, gene expression/mutation, and Standard of Care (SoC) validation data. Users may also submit service requests regarding particular models from the App directly to WuXi AppTec.

The App can be used on either Apple or Android devices and is available for download at both the Apple App store and Google Play. Its corresponding web-based browser, http://onco.wuxiapptec.com/, was launched in China in June and is also accessible globally.